Latest Institutional Sells of Biolase, Inc (BIOL)
This list provides information on the latest institutional transactions involving Biolase, Inc (BIOL) stock that were sells. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the sale has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 21, 2023
Q2 2023
|
Perkins Capital Management Inc
|
SELL
|
- |
-2.57M- 94.23% |
$180K - $873K
|
157K
$1.57K
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-12.6K- 21.09% |
$881 - $4.28K
|
47.1K
$471
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-250- 19.39% |
$17.5 - $85
|
1.04K
$10.4
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-84- 1.14% |
$5.88 - $28.6
|
7.26K
$72.6
|
|
Q1 2023 | |||||||
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-167K- 63.91% |
$46.8K - $125K
|
94.4K
$944
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-5.97K- 4.8% |
$1.67K - $4.48K
|
118K
$1.18K
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-56- 48.28% |
$15.7 - $42
|
60
$0.6
|
|
Q4 2022 | |||||||
Feb 02, 2023
Q4 2022
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-105K- 100.0% |
$62.1K - $263K
|
1
$0.01
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-39- 70.91% |
$23 - $97.5
|
16
$0.16
|